Responsible Cannabis Consultations: Scope, Records, and Escalation

A responsible cannabis consultation has a defined scope: gather relevant information with consent, explain documented product facts, record customer-reported observations and education provided, and refer medical, medication, pregnancy, serious-illness, or urgent questions to qualified professionals.

Gather information with consent and purpose

Ask about the customer’s goals and prior experience, the exact product being discussed, questions the customer wants addressed, accessibility needs, and sensitive information the customer chooses to flag for qualified clinical review. Explain why information is requested, what will be documented, and who may access it.

Identify the exact product and records

Record the product name, label, cannabinoid amount, format, package directions, warnings, lot or batch information, and any available batch record. Customer-reported observations should be identified as reports, not converted into diagnoses, treatment conclusions, or guaranteed outcomes.

Explain documented facts without prescribing

A consultant may explain documented label, cannabinoid, format, package-direction, warning, batch-record, and service-process information within the verified scope. Product education does not establish medical suitability, medicine compatibility, individualized dosing, treatment, or a predictable result.

Document education, questions, and referrals

Document product identity, customer questions, customer-reported observations, education provided, unresolved questions, and referrals. Retained records may support continuity in later conversations, but follow-up education is not clinical monitoring.

Escalate medical and urgent questions

Urgent symptoms require appropriate urgent or emergency care. Suspected interactions, pregnancy, serious illness, medication changes, diagnosis, prescribing, individualized monitoring, medical product selection, dosing, and treatment decisions belong with qualified clinicians or pharmacists.

Ask neutral service questions

• What information is required, and why?
• What will be documented, and who may access it?
• Which information is product education rather than medical judgment?
• What is the escalation path for urgent, medication, or individualized clinical questions?

King Harvest can explain its current consultation process and documented service scope. See its cannabis consultations resource. Treat that resource as company service information, not diagnosis, prescribing, medication-interaction assessment, clinical monitoring, an outcome guarantee, medical product selection, or individualized dosing or treatment.

FAQ

Important: This is general education, not medical advice. Use qualified clinicians or pharmacists for medical, medication, dosing, treatment, product-selection, and individualized clinical decisions, and use urgent or emergency care when appropriate.